The GA was used to identify a subset of features that, as a combination, provide an NK cell-based immunophenotypic ‘fingerprint’ which can determine if an asymptomatic individual with PSA levels below 20 ng ml-1 has benign prostate disease or prostate cancer. Here, KLK3 is linked to prostate carcinoma.